FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)

Blood

Volumn 95, Issue 5, 2000, Pages 1788-1796

  Guasch, Géraldine ^b   Mack, Gary J ^b   Popovici, Cornel ^b   Dastugue, Nicole ^b   Birnbaum, Daniel ^b   Rattner, Jérome B ^b   Pébusque, Marie Josèphe ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CELL CYCLE; CENTROSOME; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CHRONIC LEUKEMIA; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; MALE; MOLECULAR CLONING; MYELOPROLIFERATIVE DISORDER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0034161335     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.5.1788.005k15_1788_1796     Document Type: Article

References (49)

1. MacDonald D, Aguiar RC, Mason PJ, Goldman JM, Cross NC. A new proliferative disorder associated with chromosomal translocations involving 8p12: a review. Leukemia. 1995;9:1628-1630.
2. Slovak ML, Nemana L, Traweek ST, Stroh JA. Acute monoblastic leukemia (FAB-M5b) with t(8; 14)(p11;q11.1). Cancer Genet Cytogenet. 1991;56:237-242.
3. Bernstein R, Pinto MR, Spector I, Macdougall LG. A unique 8;16 translocation in two infants with poorly differentiated monoblastic leukemia. Cancer Genet Cytogenet 1987;24:213-220.
4. Heim S, Avanzi GC, Billstrom R. et al. A new specific chromosomal rearrangement, t(8;16) (p11; p13), in acute monocytic leukaemia. Br J Haematol. 1987;66:323-326.
5. Lai JL, Zandecki M, Jouet JP, et al. Three cases of translocation (8;16)(p11;p13) observed in acute myelomonocylic leukemia: a new specific subgroup? Cancer Genet Cytogenet. 1987;27:101-109.
6. Mitelman F, Heim S. Quantitative acute leukemia cytogenetics. Genes Chromosomes Cancer. 1992;5:57-66.
7. Stark B, Resnitzky P, Jeison M, et al. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8;16)(p11;p13), in a patient with the variant t(8;19)(p11;q13): case report and review of the literature. Leuk Res. 1995;19:367-379.
8. Velloso ER, Mecucci C, Michaux L, et al. Translocation t(8;16)(p11;p13) in acute non-lymphocytic leukemia: report on two new cases and review of the literature. Leuk Lymphoma. 1996;21:137-142.
9. Sainati L, Bolcato S, Cocito MG, et al. Transient acute monoblastic leukemia with reciprocal (8; 16)(p11;p13) translocation. Pediatr Hematol Oncol. 1996;13:151-157.
10. Lai JL, Zandecki M, Fenaux P, Preudhomme C, Facon T, Deminatti M. Acute monocytic leukemia with (8;22)(p11;q13) translocation: involvement of 8p12 as in classical t(8;16)(p11;p13). Cancer Genet Cytogenet. 1992;60:180-182.
11. Borrow J, Stanton VP Jr, Andresen JM, et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet. 1996;14:33-41.
12. Chaffanet M, Gressin L, Preudhomme C, Soenen-Cornu V, Birnbaum D, Pébusque M-J. MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer. In press.
13. Chaffanet M, Popovici C, Leroux D, et al. t(6;8), t(8;9) and t(8;13) translocations associated with myeloproliferative disorders have close or identical breakpoints on chromosome 8p12-12. Oncogens. 1998;16:945-949.
14. Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res. 1993;60:1-41.
15. Popovici C, Zhang B, Grégoire M-J, et al. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood. 1999;93:1381-1389.
16. Popovici C, Adélaïde J, Ollendorff V, et al. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8; 13)(p12;q12). Proc Natl Acad Sci U S A. 1998;95: 5712-5717.
17. Reiter A, Sohal J, Kulkarni S, et al. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood. 1998;92:1735-1742.
18. Smedley D, Hamoudi R, Clark J, et al. The t(8; 13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Hum Mol Genet. 1998;7:637-642.
19. Still IH, Cowell JK. The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13. Blood. 1998;92:1456-1458.
20. Xiao S, Nalabolu SR, Aster JC, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet. 1998;18:84-87.
21. Ollendorff V, Guasch G, Isnardon D, Galindo R, Birnbaum D, Pébusque M-J. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder associated-t(8;13) translocation. J Biol Chem. 1999;274:26,922-26,930.
22. Mitelman F. ISCN: An International System for Human Cytogenetic Nomenclature. Basel: Karger; 1995.
23. Birg F, Courcoul M, Rosnet O, et al. Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood. 1992;80:2584-2593.
24. Humeau L, Bardin F, Maroc C, et al. Phenotypic, molecular, and functional characterization of human peripheral blood CD34+/THY1+ cells. Blood. 1996;87:949-955.
25. Mack GJ, Rees, J, Sandblom O, Balczon R, Fritztor MJ, Rattner JB. Autoantibodies to a group of centrosomal proteins in human autoimmune sera reactive with the centrosome. Arthritis Rheum. 1998;41:551-558.
26. Ausubel FM, Brent R, Kingston RE, et al, eds. Current Protocols in Molecular Biology. New York: John Wiley & Sons; 1994.
27. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403-410.
28. Dionne CA, Crumley G, Bellot F, et al. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 1990;9:2685-2692.
29. Wang JK, Gao G, Goldfarb M. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol Cell Biol. 1994;14:181-188.
30. Bellot F, Crumley G, KaplowJM, Schlessinger J, Jaye M, Dionne CA. Ligand-induced transphosphorylation between different FGF receptors. EMBO J. 1991;10:2849-2854.
31. Wang JK, Goldfarb M. Amino acid residues which distinguish the mitogenic potentials of two FGF receptors. Oncogene. 1997;14:1767-1778.
32. Lupas A, van Dyke M, Stock J. Predicting coil-coils from protein sequences. Science. 1991;252:1162-1164.
33. Bongarzone I, Butti MG, Fugazzola L, et al. Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/ PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas. Genomics. 1997;42:252-259.
34. Doxsey SJ, Stein P, Evans L, Calarco PD, Kirschner M. Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell. 1994;76:639-650.
35. Bouckson-Castaing V, Moudjou M, Ferguson DJP, et al. Molecular characterization of ninein, a new coiled-coil protein of the centrosome. J Cell Science. 1996;109:179-190.
36. Landschulz WH, Johnson PF, McKnight SL. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science. 1988;240:1759-1764.
37. Busch SJ, Sassone-Corsi P. Dimer, leucine zippers and DNA-binding domains. Trends Genet. 1990;6:36-40.
38. Look AT. Genes altered chromosomal translocations in leukemias and lymphomas: the genetic basic of human cancer. In: Vogelstein B, Kinzler KW, eds. New York: McGraw-Hill; 1998:109-141.
39. Brinkley BR. Microtubule organizing centers. Ann Rev Cell Biol. 1985;1:145-172.
40. Smith MR, Wilson ML, Hamanaka R, et al. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun. 1997;234:397-405.
41. Wolf G, Elez R, Doermer A, et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene. 1997;14: 543-549.
42. Bischoff JR, Anderson L, Zhu Y, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1998;17:3052-3065.
43. Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998;20:189-193.
44. Rabbitts TH. Chromosomal translocations in human cancer. Nature. 1994;372:143-149.
45. Sawyers CL, Denny CT. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about. Cell. 1994;77:171-173.
46. Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. Proc Natl Acad Sci U S A. 1996;93:14,845-14,850.
47. Okuda K, Smith L, Griffin JD, Foster R. Signaling functions of the tyrosine residues in the betac chain of the granulocyte-macrophage colony-stimulating factor receptor. Blood. 1997;90:4759-4766.
48. Chesi M, Nardini E, Brents LA, et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet. 1997;16:260-264.
49. Lorenzi MV, Horii Y, Yamanaka R, Sakaguchi K, Miki T. FRAG1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement. Proc Natl Acad Sci U S A. 1996;93:8956-8961.